Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Annovera and Tampon Co-Usage PK Study
NCT04272008Phase 1Completed
- Sponsor
- TherapeuticsMD
- Start
- Mar 2020
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 1, randomised, open-label trial of segesterone in contraception (2 arms), sponsored by TherapeuticsMD. Primary endpoint: Area Under the Curve (Days 2 to 3). Started Mar 2020; status: completed.
02
Drugs
segesterone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04272008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04272008.